Trial active/not recruiting; primary completion est. Nov 2026. No posted results or disclosures for selected endpoint (Pct chg BW at Wk 80, Reta vs Tirz) in any source. Evidence incomplete; no qualifying disclosure.
Reviewed for the 2026-10-06 site refresh. The exact registry record was re-fetched and has no posted results. The monitor found no qualifying disclosure matching the locked endpoint. A YES or NO resolution is not supported; retain the open market and revisit when new evidence arrives. This closes the administrative review item without changing the market outcome.
Active, not recruiting. Primary completion estimated Nov 2026. No results posted.
TRIUMPH-5 (Reta vs tirzepatide head-to-head) has not reported yet.